Veranstaltungen

Max-Planck-Institut für Innovation und Wettbewerb, München, Raum 313
 

We investigate the impact of the introduction of patent rights for software inventions in the U.S. on academic computer scientists’ publication output. Difference-in-difference estimations that compare U.S. academic computer scientists working on software to (1) U.S. academic scientists working on hardware and (2) European university scientists working on software reveals that the introduction of software patents in the U.S. led to a decrease of (citation-weighted) publications as compared to U.S. computer scientists working on hardware and as compared to the European peers. The effect is stronger for scientists at the left-hand side of the ability distribution. This pattern is consistent with a simple model of time allocation between patenting and publishing. (joint work with Laurent Bergé and Thorsten Doherr)

Ansprechpartner: Felix Pöge

Max-Planck-Institut für Innovation und Wettbewerb, Raum E10

Moderation: Jörg Hoffmann

Das Institut würdigte seinen ehemaligen Direktor mit einer Sonderveranstaltung im Patentrechtszyklus mit anschließendem Empfang.

Als Redner konnten enge Weggefährten gewonnen werden: Prof. Dr. Rudolf Kraßer, Dr. Rainer Moufan, Prof. Dr. Bojan Pretnar, Wolrad Prinz zu Waldeck und Pyrmont äußerten sich zu besonders bedeutsamen Themen des Immaterialgüterrechts, die auch Straus‘ Forschungsarbeit bis heute prägen.

Meldung:„Joseph Straus wird 80”

From 10 to 11 December 2018, the Max Planck Institute for Innovation and Competition will organize the first junior researcher workshop:

From Science to Innovation

The goal of the workshop is to stimulate a rigorous in-depth discussion of a number of selected research papers. It offers PhD students and junior Post-docs an opportunity to present their work, receive feedback, and connect with peers from other departments. Each paper will be discussed by a discussant. The workshop will be held at the Max Planck Institute for Innovation and Competition, room E10.

Overview
The workshop will focus on the following areas:

• Economics of Science and Innovation
  

• Human Capital in the Science Production Function
• Financial Incentives in Science
• Corporate Strategy to Access Scientific Knowledge
• Organization of Innovation within Firms
• Knowledge Spillovers between Firms




• Legal Analysis of Knowledge Approbability
  

• Knowledge Appropriability in R&D Partnerships
• Big Data Ownership and Accessability

We are happy to announce Jeff Furman (Boston University & NBER) as our keynote speaker who will also provide feedback during sessions.

Program
The full program is available here. Should you be interested in attending the workshop without paper presentation, please contact us directly no later than October 31. There is only a small number of places available.

Max Planck Institute for Innovation and Competition, Room E10

Further information
Any questions concerning the From Science to Innovation workshop should be directed to Dennis Byrski.

Ganztägiger Workshop

Anprechperson: Dr. Matthias Lamping

Website IPDR-Forum

Max-Planck-Institut für Innovation und Wettbewerb, München, Raum 313

Considering that both patents and trade secrets can promote knowledge diffusion via licensing, we compare patents and secrets on the way they facilitate diffusion through non-exclusive licensing. This comparison is important because AI algorithms are not patentable. Patents differ from trade secrets on the easiness of imitation when licensed to many downstream producers. In view of this, we argue that secrets are better in defending one’s monopoly under the threat of imitation, inducing market failure on the diffusion of AI. We also find a non-linear relationship between patent strength and the diffusion of ideas, i.e., patents of intermediate patent strength are best as diffusion instruments.

Ansprechpartner: Dr. Fabian Gaessler

Toshiko Takenaka, Hunter Simpson Professor of Technology Law, University of Washington School of Law

Max-Planck-Institut für Innovation und Wettbewerb, Raum E-10

Falls Sie teilnehmen möchten, senden Sie bitte bis zum 20. November eine E-Mail an elisabeth.amler(at)ip.mpg.de.

Max-Planck-Institut für Innovation und Wettbewerb, München, Raum 313

We theoretically derive a simple rule for the optimal patent breadth and duration of pharmaceutical patents. The rule requires only data on generic firms’ investments in imitation prior to the expiry of originator patents. We then test the rule using a unique patent level data set from the US. Paragraph IV challenges offer a clear metric of imitation and patent term extensions create the variation in patent term. Using two quasi-experimental approaches and newly constructed data, we document that extending patent length increases incentives to imitate whereas broadening patents reduces these incentives. Our results together suggest that effective terms of new drug patents should be made shorter and delays in commercialization of new drugs should be compensated by increasing breadth.

Ansprechpartner: Felix Pöge

Vorab wird im Rahmen der „Aktuellen Viertelstunde“ Frau Dr. Katharina Kolb, Associate bei Milbank in München, über die „Reichweite der Schadensvermutung im Kartellschadensersatzrecht im Lichte der jüngsten Rechtsprechung“ referieren.

Wie immer lädt das Münchner Kartellrechtsforum anschließend zum informellen Austausch bei Getränken und Häppchen ein.

Wir freuen uns auf Ihr Kommen und bitten um Anmeldung bis zum 15.11.2018 bei delia.zirilli@ip.mpg.de.